학술논문

The strategic use of novel smallpox vaccines in the post-eradication world
Document Type
Academic Journal
Source
Expert Review of Vaccines. July 2011, Vol. 10 Issue 7, p1021, 15 p.
Subject
Zoonoses
Biological weapons
Weapons of mass destruction
Vaccines
Smallpox vaccine
Health
Language
English
ISSN
1476-0584
Abstract
We still face a threat of orthopoxviruses in the form of biological weapons and emerging zoonoses. Therefore, there is a need to maintain a comprehensive defense strategy to counter the low-probability, high-impact threat of smallpox, as well as the ongoing threat of naturally occurring orthopoxvirus disease. The currently licensed live-virus smallpox vaccine ACAM2000 is effective, but associated with serious and even life-threatening adverse events. The health threat posed by this vaccine, and other previously licensed vaccines, has prevented many first responders, and even many in the military, from receiving a vaccine against smallpox. At the same time, global immunity produced during the smallpox eradication campaign is waning. Here, we review novel subunit/component vaccines and how they might play roles in unconventional strategies to defend against emerging orthopoxvirus diseases throughout the world and against smallpox used as a weapon of mass destruction.
Author(s): Joseph W Golden [sup.1] , Jay W Hooper [sup.[[dagger]]] [sup.2] Keywords : biological warfare; disease eradication; DNA vaccines; humoral immunity; orthopoxvirus; subunit vaccines; vaccination; variola virus; viral vectors; zoonoses [...]